Late toxicity | Cetuximab + CCRT (n = 62) | CCRT (n = 124) | P |
---|---|---|---|
Xerostomia* | 11 (17.7%) | 27 (21.8%) | 0.52 |
Hearing loss* | 13 (21.0%) | 23 (18.5%) | 0.694 |
Skin dystrophy | 3 (4.8%) | 5 (4.0%) | 1 |
Neck fibrosis | 6 (9.7%) | 17 (13.7%) | 0.431 |
Trismus | 2 (3.2%) | 11 (8.9%) | 0.263 |
Radiation encephalopathy | 1 (1.6%) | 9 (7.3%) | 0.108 |
Cranial nerve palsy | 7 (11.3%) | 9 (7.3%) | 0.364 |
*Grade 2–4 toxicities |